Canadian Regulatory Context BPC-157 has not been approved for human medical use by Health Canada or any other major regulatory body, including the U.S
Neuroprotection: Preliminary studies suggest Dihexa might help combat neurodegenerative processes by protecting neurons from damage and possibly slowing cognitive decline
Heres to protecting your brain with evidence, not hype
Everything here is research-use-only and not for human consumption
However, if you inject or consume a very concentrated version of these juices, the concentrate has the ability to allow for very high levels of healing activity anywhere in the body
Current TB-500 / BPC-157 blend research focuses on peptide-based signaling models involving cellular migration, cytoskeletal organization, connective tissue-associated pathways, and coordinated molecular response systems